Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells

Molecules. 2022 Oct 9;27(19):6709. doi: 10.3390/molecules27196709.

Abstract

In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle analysis, RT-PCR, DNA fragmentation, and Western blotting techniques. Cytotoxic results showed that compound (4) had a significant cytotoxic effect against HL60 cells (IC50 = 8.09 µM), while compound (8b) had a noticeable activity against HepG2 cells (IC50 = 13.14 µM). Compounds (4) and (8b) mediated their cytotoxicity via PI3K/AKT pathway inhibition. These results were assured by molecular docking studies. These results support further exploratory research focusing on the therapeutic activity of coumarin derivatives as cytotoxic agents.

Keywords: MTT assay; PI3K/AKT; apoptosis; coumarin derivatives; docking; drug discovery; industrial development.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Apoptosis
  • Coumarins / pharmacology
  • Cytotoxins / pharmacology
  • Drug Screening Assays, Antitumor
  • HL-60 Cells
  • Hep G2 Cells
  • Humans
  • Molecular Docking Simulation
  • Neoplasms*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Coumarins
  • Cytotoxins
  • Proto-Oncogene Proteins c-akt